Optimizing Care for Patients With Triple-Negative Breast Cancer Through Pharmacist Interventions in Supportive Care and Toxicity Management

Optimizing Care for Patients With Triple-Negative Breast Cancer Through Pharmacist Interventions in Supportive Care and Toxicity Management is organized by Pharmacy Times Continuing Education (PTCE).,Release date: August 26, 2022,Expiration date: August 26, 2023,Description:,Pharmacists have important roles in ensuring medication adherence and providing supportive care management to patients with triple-negative breast cancer (TNBC). This module will review strategies for pharmacists to optimize and personalize the management of patients with TNBC. Specific toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors, immune checkpoint inhibitors, and antibody-drug conjugates will be discussed, with a focus on the pharmacist’s role in monitoring for and mitigating the adverse effects of therapy. In addition, counseling points regarding medication administration, potential drug interactions, and barriers to adherence will be covered to assist pharmacists in providing individualized supportive care for patients with TNBC. Counseling videos incorporated throughout this activity will provide pharmacists with key pearls to provide when educating patients with TNBC about treatment expectations, adverse effect management, and provision of supportive care.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Identify the role of the pharmacist in the provision of supportive care for patients with triple-negative breast cancer (TNBC),• Analyze the toxicities specific to novel agents such as poly (ADP-ribose) polymerase (PARP) inhibitors, immune checkpoint inhibitors, and antibody-drug conjugates for the treatment of TNBC,• Develop a plan to effectively mitigate, monitor, or treat toxicities associated with novel drug therapies for the treatment of TNBC